The awards were presented Research to Care call.sponsored by Sanofi and dedicated this year non-small cell lung cancer. The projects were selected by an independent expert jury chaired by Silvia NovelloProfessor of Medical Oncology at the University of Turin, Head of the Department of Lung Oncology at the AOU San Luigi Gonzaga in Orbassano (TO) and President of the WALCE Association (Women Against Lung Cancer in Europe) Onlus.

“With 43,000 diagnoses in Italy alone in 2022, lung cancer is still one of the most common neoplasms today, the second most common in men after prostate cancer and the third most common in women after breast and colon cancer,” explains Novello. “Continued research is essential. The number and level of research projects we have had the privilege of reviewing and the projects honored today are further testament to the capabilities of our country’s researchers. The approach, technologies and skills employed also allow us to map the direction in which research is moving. In Italy, like in the rest of the world, Independent research is a hotbed of innovative ideas which can only be found in the benefits
Corporate support.

The Sanofi call is aimed at universities, hospitals and research institutes and was created with this goal in mind Promotion of Italian research and innovation in oncology and provided a first prize worth one hundred thousand euros. The winning project “Research to Care” was submitted by Julia MazzaschiUniversity of Parma – Department of Medicine and Surgery, and deals with the identification of genomic alterations of tumors to support the development of personalized therapeutic strategies and targeted treatments.